Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by Medtronic

evt | Article | January 2022

Women in the Vascular Field: Challenges, Solutions, and Moving Forward

With Gloria Salazar, MD, FSIR; Venita Chandra, MD, FACS; Katharine McGinigle, MD, MPH, FACS, FSVS; and Jean Starr, MD, FACS, DFSVS

Sponsored by Cook Medical

evt | Article | December 2021 Supplement

Peripheral Arterial Disease | Satisfying the Practitioner’s Need for Long-Term Data, Transparency

With John Phillips, MD; Venita Chandra, MD; and Michael Wilderman, MD, FACS

evt | Article | August 2021

Enlarging Aortoiliac Aneurysm With Combined Hostile Neck and Iliofemoral Access Challenges

Moderator: Brant W. Ullery, MD, MBA, FACS, FSVS;
Panelists: Venita Chandra, MD; Sukgu Han, MD, MS; and Grace J. Wang, MD, MSCE

Sponsored by Penumbra, Inc.

evt | Article | July 2019

Mechanical Power Aspiration With the Indigo® System: Rethinking Clot Removal

With Frank R. Arko III, MD; James F. Benenati, MD; Venita Chandra, MD; Paul Isenbarger, MD; Minhaj S. Khaja, MD, MBA; Maureen P. Kohi, MD, FSIR; and Kumar Madassery, MD

Advertisement

Advertisement

Sponsored by Gore & Associates

evt | Article | June 2015 Supplement

Session 2: Bypass in the world of “endovascular first”: How does it fit in today's treatment algorithm?

With Ross Milner, MD; Venita Chandra, MD; Michael S. Conte, MD

evt | Article | November 2018

Ask the Experts: Aortoenteric/Aortobronchial Fistulas: Is TEVAR Acceptable?

Experts share their strategies for first-line treatment in these very challenging and often morbid presentations.

With Ali Azizzadeh, MD, FACS; Timur P. Sarac, MD; Venita Chandra, MD; and Raghuveer Vallabhaneni, MD, FACS

evt | Article | May 2020

Ask the Experts: Repeat Revascularization in Rutherford 5/6 Patients: What Is Your Point of No Return?

Approaches to initial and repeat revascularization while considering patient preference and disease characteristics.

With Venita Chandra, MD, and Sabine Steiner, MD

evt | Article | September 2022

Roundtable Discussion: The Future of the Vascular Meeting

Leading physicians who play an active role in the development of meetings in the vascular space offer insight into the evolving landscape of conferences.

Moderator: Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed(ClinEpi);
Panelists: Venita Chandra, MD; Afshin Gangi, MD, PhD; Tara M. Mastracci, MD, FRCSC; and Parag J. Patel, MD, MS, FSIR

Sponsored by Endologix

evt | Article | August 2017

Discussing the Treatment of AAAs in Women and Early Results From the LUCY Study

The LUCY trial advisory board members provide their interpretation of the initial impact of the study's early results.

With Jennifer Ash, MD; Venita Chandra, MD; Monica Hunter, MD; Eva Rzucidlo, MD; and Ageliki Vouyouka, MD

evt | Article | August 2025

How Has Retrograde Access Changed Your CLTI Practice and Algorithms?

Retrograde access is an integral and routine component of CLTI revascularization strategies, offering improved success rates for complex occlusion patterns and crossing CTOs and an alternative when a traditional antegrade approach fails.

With John H. Rundback, MD, FAHA, FSVM, FSIR; Venita Chandra, MD; and S. Jay Mathews, MD, MS, FACC, FSCAI

evt | Article | August 2023

Curbside Consult: What Are the Biggest Unmet Needs in…

Physicians discuss the biggest challenge or area of future growth in their respective disease focuses, including improved systems of care, device innovation, optimized treatment methods, and better understanding of disease pathophysiology.

With James Milburn, MD, FACR; Nora Tabori, MD; James B. Spies, MD, MPH; Kathleen Gibson, MD; Germano Melissano, MD; Raghu Kolluri, MD, MS, RVT; Sherene Shalhub, MD, MPH, FACS, DFSVS; Venita Chandra, MD; Steve Elias, MD, FACS, FAVLS, DABVLM; and Erin H. Murphy, MD, FACS

evt | News | September 30, 2025

FastWave Names Leadership for Pivotal Trial of Artero Electric IVL System

September 30, 2025—FastWave Medical, a developer of intravascular lithotripsy (IVL), announced the appointment of the principal investigators and steering committee for the upcoming United States investigational device exemption pivotal trial of the company’s Artero peripheral electric IVL system.

evt | News | November 4, 2024

Disrupt PAD BTK II Evaluates Shockwave IVL System to Treat Calcified Lesions

November 4, 2024—The Disrupt PAD BTK II study’s 30-day outcomes were revealed.

evt | News | February 13, 2017

Endologix's Ovation LUCY Study Completes Patient Enrollment

February 14, 2017—Endologix, Inc. announced that it has completed patient enrollment for the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for Abdominal Aortic AneurYsm Repair) study.

Sponsored by Cook Medical

evt | Article | December 2021 Supplement

Providing a Comprehensive Approach to Vascular Disease

By Mark Breedlove

evt | News | November 4, 2024

Medtronic Presents Studies on Utility of Atherectomy to Treat PAD

November 4, 2024—Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.

evt | News | September 16, 2024

Shockwave E8 Peripheral IVL Catheter Launched

September 16, 2024—Shockwave Medical, Inc., part of Johnson & Johnson MedTech, announced the FDA clearance and full United States launch of the Shockwave E8 peripheral intravascular lithotripsy (IVL) catheter.

evt | Article | August 2021

Meeting the Challenge

By John A. Kaufman, MD

evt | News | July 11, 2023

Cagent Vascular’s Serranator Device in BTK Arteries Compared to POBA in RECOIL Study

July 11, 2023—Cagent Vascular, a Pennsylvania-based developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its below-the-knee (BTK) Serranator RECOIL study.

evt | News | November 22, 2021

Shockwave’s Disrupt BTK II Postmarket Study Commences Enrollment

November 22, 2021—Shockwave Medical, Inc., a developer of intravascular lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced the start of the Disrupt BTK II postmarket study to assess the safety, effectiveness, and optimal clinical use of the Shockwave Peripheral IVL System for the treatment of calcified peripheral lesions below the knee (BTK), including some of the most challenging patients with critical limb ischemia (CLI).


1
2

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button